S7 E11: Interview with Dr Anna Martinez on Epidermolysis Bullosa; Finerenone for CKD without T2DM; Retatrutide monotherapy for T2DM

NO
PHARMACEUTICAL INFLUENCE
NO PHARMACEUTICAL INFLUENCE
12th June 2026

If you are having difficulties listening to this Podcast, try to play this episode in Spotify

Welcome to the Hot Topics podcast from NB Medical with Dr Neal Tucker. Lots going on in this new episode! 

Three new pieces of research and an interview with Dr Anna Martinez, consultant paediatric dermatologist at GOSH, talking about a skin fragility condition many of us may not have heard of before - epidermolysis bullosa - in conjunction with DEBRA, the leading charity for EB awareness and research. 

In research, we look at two papers published this week in finerenone. Does it have a role in CKD management in patients without diabetes, and if so, how good is it?

Second, retatruide - the latest injectable weight loss medication making a splash across the headlines - could it be used as monotherapy for recent onset type 2 diabetes?

Resources

NB Medical Epidermolysis bullosa free online educational module

DEBRA

NEJM Finerenone for CKD

Lancet Finerenone MA

Lancet Retatrutide for early T2DM


Join us at one of our upcoming courses or live webinars